The global women’s health diagnostics market size reached US$ 21.62 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 35.7 Billion by 2027, exhibiting at a CAGR of 8.10% during 2022-2027.

Women’s health diagnostics refers to the diagnosis and treatment of various biological and psychosocial conditions among female patients. It assists in analyzing and detecting several health issues, such as birth control, gynecologist disorders, breast cancer, sexually transmitted infections, osteoporosis, heart disease, pregnancy and childbirth, and other benign conditions.

Global Women’s Health Diagnostics Industry Trends and Drivers:

The global market is majorly driven by the rising incidences of chronic and lifestyle-related disorders. Furthermore, the increasing number of imaging and diagnostic centers on the global level represents another major factor influencing the market positively. Along with this, the growing health awareness among the female population regarding the benefits of early diagnosis is creating a positive outlook for the market.

Get a PDF Sample for more detailed market insights:

Moreover, the increasing number of patients with ovarian, breast, and cervical cancer across the globe has increased the demand for accurate and effective diagnostics, which, in turn, is contributing to the market growth. Additionally, the rising rates of infertility among the female population and the increasing prevalence of various pregnancy-related complications are propelling the need for women’s health diagnostics solutions.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

The report has segmented the market on the basis of region, type, application and end user.

Breakup by Type:

Based on the type, the market has been categorized into diagnostic devices (biopsy device, imaging and monitoring devices, and accessories and consumables) and diagnostic tests (breast cancer testing, PAP smear and HPV test, pregnancy testing and ovulation testing, and others).

Breakup by Application:

The market has been divided based on the application into breast cancer, infectious disease testing, osteoporosis testing, pregnancy and fertility testing, sexually transmitted disease testing, and others.

Breakup by End User:

On the basis of the end user, the market has been bifurcated into hospital and diagnostics centers and home care.

Breakup by Region:

Region-wise, the market has been segregated into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization. 

Also Read:

Gas Chromatography Market 2026: Growth, Trends Report

Dental 3D Printing Market to Reach US$ 4.92 Billion by 2027

Table of Contents:

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

4.1    Overview
4.2    Key Industry Trends
5    Global Women’s Health Diagnostics Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6    Market Breakup by Type
6.1    Diagnostic Devices
6.1.1 Market Trends
6.1.2 Key Segments Biopsy Device Imaging and Monitoring Devices Accessories and Consumables
6.1.3 Market Forecast
6.2    Diagnostic Tests
6.2.1 Market Trends
6.2.2 Key Segments Breast Cancer Testing PAP Smear and HPV Test Pregnancy Testing and Ovulation Testing Others
6.2.3 Market Forecast
7    Market Breakup by Application
7.1    Breast Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Infectious Disease Testing
7.2.1 Market Trends
7.2.2 Market Forecast
7.3    Osteoporosis Testing
7.3.1 Market Trends
7.3.2 Market Forecast
7.4    Pregnancy and Fertility Testing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5    Sexually Transmitted Disease Testing
7.5.1 Market Trends
7.5.2 Market Forecast
7.6    Others
7.6.1 Market Trends
7.6.2 Market Forecast
8    Market Breakup by End User
8.1    Hospital and Diagnostics Centers
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Home Care
8.2.1 Market Trends
8.2.2 Market Forecast

To be Continued……………..


Please enter your comment!
Please enter your name here